# Oral Dosage Form New Animal Drugs; Clindamycin
> **Food and Drug Administration** · Final rule. · Published 2002-08-27 · Effective 2002-08-27 · 67 FR 54954
## Document
- **Document number:** 02-21733
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 67 FR 54954
- **CFR reference:** 21 CFR 520
- **Publication date:** 2002-08-27
- **Effective date:** 2002-08-27
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by Pharmacia and Upjohn Co. for clindamycin hydrochloride oral dosage forms. The supplement to the NADA for an oral liquid provides for an expanded dose range for the use of clindamycin hydrochloride in both dogs and cats for the treatment of certain bacterial infections. The supplement to the NADA for oral capsules provides for an expanded dose range in dogs and for use of a 300-milligram (mg) strength capsule.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2002/08/27/02-21733/oral-dosage-form-new-animal-drugs-clindamycin)
---
*AI Analytics · CC0 1.0*